Tags

Type your tag names separated by a space and hit enter

Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes.
Evid Based Med. 2009 Dec; 14(6):168.EB

Authors+Show Affiliations

Women's College Hospital, Ontario, Canada.

Pub Type(s)

Comment
Journal Article

Language

eng

PubMed ID

19949171

Citation

Lipscombe, Lorraine L.. "Rosiglitazone Was Non-inferior to Metformin Plus Sulphonylurea for CV Events but Increased Risk of HF and Fractures in Type 2 Diabetes." Evidence-based Medicine, vol. 14, no. 6, 2009, p. 168.
Lipscombe LL. Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes. Evid Based Med. 2009;14(6):168.
Lipscombe, L. L. (2009). Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes. Evidence-based Medicine, 14(6), 168. https://doi.org/10.1136/ebm.14.6.168
Lipscombe LL. Rosiglitazone Was Non-inferior to Metformin Plus Sulphonylurea for CV Events but Increased Risk of HF and Fractures in Type 2 Diabetes. Evid Based Med. 2009;14(6):168. PubMed PMID: 19949171.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes. A1 - Lipscombe,Lorraine L, PY - 2009/12/2/entrez PY - 2009/12/2/pubmed PY - 2009/12/2/medline SP - 168 EP - 168 JF - Evidence-based medicine JO - Evid Based Med VL - 14 IS - 6 SN - 1473-6810 UR - https://www.unboundmedicine.com/medline/citation/19949171/Rosiglitazone_was_non_inferior_to_metformin_plus_sulphonylurea_for_CV_events_but_increased_risk_of_HF_and_fractures_in_type_2_diabetes_ L2 - http://ebm.bmj.com/cgi/pmidlookup?view=long&pmid=19949171 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.